FDA signs off on Merck’s cholesterol-lowering pill — the first oral treatment of its kind

Sources & evidence

Who reported what and when — read across platforms to understand the story.

• news3 hr ago

  FDA signs off on Merck’s cholesterol-lowering pill — the first oral treatment of its kind

  The pill, branded as Lipfendra, is intended to treat patients with hypercholesterolemia, including those with ​hereditary forms of the disease, which causes elevated levels of LDL.

  Open link